Kaleido Biosciences, Inc. Banner Image

Kaleido Biosciences, Inc.

  • Ticker KLDO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Kaleido Biosciences, Inc. Logo Image
  • 51-200 Employees
  • Based in Lexington, Massachusetts
Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health. The Company has built a proprietary product platform to enable the rapid and cost-efficient discovery and development of novel Microbiome Metabolic Therapies (MMT™). MMTs are designed to modulate the metabolicMore output and profile of the microbiome by driving the function and distribution of the gut’s existing microbes. Kaleido is advancing a broad pipeline of MMT candidates with the potential to address a variety of diseases and conditions with significant unmet patient needs.
Kaleido Biosciences, Inc.

Most Recent Annual Report

Kaleido Biosciences, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports